David E Nix
- Professor, Pharmacy Practice-Science
- Professor, BIO5 Institute
- Associate Professor, Medicine
- Member of the Graduate Faculty
- (520) 626-4814
- Roy P. Drachman Hall, Rm. 211 J
- Tucson, AZ 85721
- dnix1@arizona.edu
Biography
Dr. Nix is a Professor of Pharmacy Practice and Science. He received his B.S. (Pharmacy) in 1982 and Pharm.D. in 1984 from The University of Georgia. From 1984-1986, he completed a postdoctoral Fellowship in Infectious Disease Pharmacotherapy and Pharmacokinetics from The State University of New York at Buffalo.
From 1986 to 1996, he served as Program Director, Antimicrobial Research, Assistant Director, and Associate Director of The Clinical Pharmacokinetics Laboratory, Millard Fillmore Hospital. Dr. Nix was responsible for directing the Clinical Pharmacology Unit and carrying out clinical and laboratory research involving antimicrobial drugs. Dr. Nix joined The University of Arizona Faculty in 1996. Current responsibilities include teaching (infectious diseases), Infectious Disease Clinical Pharmacist (Banner University Medical Center, Tucson, Arizona), and research. Research Interests have included Development of an orphan drug (Nikkomycin Z) for treatment of Valley Fever. Dr. Nix has authored or contributed to over 100 research papers. Dr. Nix is Board certified in Pharmacotherapy (BCPS), Infectious Disease Pharmacy (BCIDP), and Applied Pharmacology (American Board of Clinical Pharmacology). He has been a member/alternate member of the UA IRB for more than 20 years, and is currently in charge of site review for human research at the College of Pharmacy. Dr. Nix has been co-director of the Antimicrobial Stewardship program for several years at BUMC-T, and provides clinical pharmacy service in Transplant Infectious Disease.
Degrees
- Pharm.D. Pharmacy
- University of Georgia, Athens, Georgia, United States
- Cisplatin-induced renal toxicity
- B.S. Pharmacy
- University of Georgia, Athens, Arizona, United States
Work Experience
- Banner University Medical Center-Tucson Campus (2017 - Ongoing)
- University of Arizona, Tucson, Arizona (2009 - Ongoing)
- University of Arizona, Tucson, Arizona (2004 - Ongoing)
- University of Arizona, Tucson, Arizona (1996 - 2009)
- The Clinical Pharmacokinetics Laboratory, Millard Fillmore Hospital (1995 - 1996)
- The Clinical Pharmacokinetics Laboratory, Millard Fillmore Hospital (1989 - 1995)
- The Clinical Pharmacokinetics Laboratory, Millard Fillmore Hospital (1986 - 1989)
Awards
- 2016 Outstanding Reviewer
- Pharmacotherapy - American College of Clinical Pharmacy, Fall 2016
- Nominated Clinical Teacher of Year
- Class of 2015, Spring 2015 (Award Nominee)
Licensure & Certification
- Diplomat in Applied Pharmacology, American Board of Clinical Pharmacology (1992)
- Board Certified Pharmacotherapy Specialist, Board of Pharmaceutical Specialties (1992)
- Pharmacist, Arizona State Board of Pharmacy (1997)
Interests
Research
Drug Development - Currently working on an orphan drug (Nikkomycin Z) for treatment of Valley FeverInterested in Pharmacokinetics, Pharmacodynamics and Drug Interactions involving anti-infective drugs.
Teaching
Infectious Diseases - Pharmacology of anti-infective drugs and therapeutics relating to treatment of infectious diseases.Application of pharmacokinetics in treatment of infectious diseases
Courses
2024-25 Courses
-
Pharmacokinetics
PHPR 818 (Fall 2024) -
Pharmacotherapeutics IV
PHPR 860D (Fall 2024)
2023-24 Courses
-
Infectious Diseases
PHPR 824 (Spring 2024) -
Medical Microbiology
PHPR 813 (Spring 2024) -
Pharmacokinetics
PHPR 818 (Fall 2023) -
Pharmacotherapeutics IV
PHPR 860D (Fall 2023)
2022-23 Courses
-
Infectious Diseases
PHPR 824 (Spring 2023) -
Medical Microbiology
PHPR 813 (Spring 2023) -
Pharmacokinetics
PHPR 818 (Fall 2022) -
Pharmacotherapeutics IV
PHPR 860D (Fall 2022)
2021-22 Courses
-
Infectious Diseases
PHPR 824 (Spring 2022) -
Medical Microbiology
PHPR 813 (Spring 2022) -
Pharmacokinetics
PHPR 818 (Fall 2021) -
Pharmacotherapeutics IV
PHPR 860D (Fall 2021)
2020-21 Courses
-
Infectious Diseases
PHPR 824 (Spring 2021) -
Medical Microbiology
PHPR 813 (Spring 2021) -
Pharmacokinetics
PHPR 818 (Fall 2020) -
Pharmacotherapeutics IV
PHPR 860D (Fall 2020)
2019-20 Courses
-
Medical Microbiology
PHPR 813 (Spring 2020) -
Writing a Research Proposal
PHPR 862 (Spring 2020) -
Infectious Diseases
PHPR 824 (Fall 2019) -
Pharmacokinetics Disc
PHPR 808A (Fall 2019) -
Pharmacokinetics Disc
PHSC 508A (Fall 2019)
2018-19 Courses
-
Pharmacotherapeutics
PHPR 875A (Spring 2019) -
Writing a Research Proposal
PHPR 862 (Spring 2019) -
Independent Study
PHPR 899 (Winter 2018) -
Infectious Diseases
PHPR 824 (Fall 2018) -
Pharmacokinetics Disc
PHPR 808A (Fall 2018) -
Pharmacokinetics Disc
PHSC 508A (Fall 2018)
2017-18 Courses
-
Chemo Infectious Disease
PCOL 536A (Spring 2018) -
Chemo Infectious Disease
PCOL 836A (Spring 2018) -
Pharmacotherapeutics
PHPR 875A (Spring 2018) -
Pharmacy Practice Project
PHPR 896B (Spring 2018) -
Writ Prop Scientfic Std
PHPR 862 (Spring 2018) -
Infectious Diseases
PHPR 824 (Fall 2017) -
Pharmacokinetics Disc
PHPR 808A (Fall 2017) -
Pharmacy Prac Project
PHPR 896A (Fall 2017)
2016-17 Courses
-
Chemo Infectious Disease
PCOL 536A (Spring 2017) -
Chemo Infectious Disease
PCOL 836A (Spring 2017) -
Pharmacotherapeutics
PHPR 875A (Spring 2017) -
Pharmacy Practice Project
PHPR 896B (Spring 2017) -
Research
CTS 900 (Spring 2017) -
Thesis
CTS 910 (Spring 2017) -
Writ Prop Scientfic Std
PHPR 862 (Spring 2017) -
Infectious Diseases
PHPR 824 (Fall 2016) -
Pharmacokinetics Disc
PHPR 808A (Fall 2016) -
Pharmacy Prac Project
PHPR 896A (Fall 2016) -
Thesis
CTS 910 (Fall 2016)
2015-16 Courses
-
Chemo Infectious Disease
PCOL 836A (Spring 2016) -
Writ Prop Scientfic Std
PHPR 862 (Spring 2016)
Scholarly Contributions
Books
- More infoSeries of books/on line case studies that provide continuing education for pharmacotherapy specialists. Note role was listed at "editor" however the role is actually Faculty Panel Chair for the Infectious Disease Book in the series.
Chapters
Journals/Publications
Presentations
Poster Presentations
Reviews
- More infoCreatinine-based estimates of glomerular filtration rate (GFR) have been the standard for classifying kidney function and guiding drug dosing for over 5 decades. There have been many efforts to compare and improve different methods to estimate GFR. The National Kidney Foundation recently updated the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equations without race for creatinine (CKD-EPIcr_R) and creatinine and cystatin C (CKD-EPIcr-cys_R), and the 2012 CKD-EPI equation based on cystatin C (CKD-EPIcys) remains. The focus of this review is to highlight the importance of muscle atrophy as a cause for overestimation of GFR when using creatinine-based methods.
Case Studies
- More infoTo describe the use of high-dose posaconazole in 2 pediatric patients who received bone marrow transplant (BMT) and highlight concerns regarding posaconazole absorption.
Other Teaching Materials
Others
- More infoTo determine the time above minimum inhibitory concentration (T > MIC) and serum bactericidal activity of five oral cephalosporins against two strains of Haemophilus influenzae.